Rentokil rises after selling off French workwear business

Rentokil Initial PLC shares rose 1.6% after announcing an agreement to sell its French workwear business to HIG Capital for up to €370 million in cash proceeds. The deal, expected to close by year-end, has a gross enterprise value of roughly €410 million and includes a potential €30 million earn-out based on 2026 performance. CEO Andy Ransom stated the sale simplifies the business, strengthens the balance sheet, and enhances cash generation, aligning with the company's focus on Pest Control and Hygiene & Wellbeing, with net proceeds earmarked for debt reduction and core business investment.

Analysis

Rentokil Initial PLC (LSE:RTO) shares rose 1.6% following the announcement of an agreement to sell its French workwear, flat linen, and pharmaceutical clean room business to HIG Capital. The deal involves a gross enterprise value of approximately €410 million, with expected cash proceeds of up to €370 million, including a potential €30 million earn-out based on the business's 2026 performance. CEO Andy Ransom highlighted that this divestiture simplifies Rentokil's operations, strengthens its balance sheet, and enhances cash generation, aligning with the company's strategic focus on its core Pest Control and Hygiene & Wellbeing divisions. This strategic shift is further evidenced by pest control's contribution to group revenue increasing from 44% ten years ago to over 80% today. The net proceeds from the sale, anticipated to complete by the end of the calendar year, are designated for general corporate purposes, notably debt reduction and investment in these core areas. The market's reaction and the associated strongly positive sentiment score of 0.7 (0.75 specifically for RTO) suggest investor confidence in this M&A and restructuring initiative, which is expected to improve company fundamentals and outlook.

Key Decisions for Investors

• Investors should view this transaction as a positive catalyst, reflecting management's commitment to simplifying the business model and concentrating on higher-margin, market-leading segments.
• Consider the deleveraging impact and potential for enhanced capital deployment into core growth areas, which could support future earnings accretion and an improved valuation.
• Monitor the successful completion of the deal by year-end and look for subsequent communications regarding the specific allocation of proceeds towards debt reduction and reinvestment in Pest Control and Hygiene & Wellbeing.